View in EDS

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.

Saved in:
Bibliographic Details
Title: A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Authors: Gressin R; Onco-Hematology Department, Grenoble University Hospital rgressin@chu-grenoble.fr mary.callanan@chu-dijon.fr.; INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble-Alpes, Institute for Advanced Biosciences, Grenoble., Daguindau N; Hematology Department, Annecy Hospital., Tempescul A; Hematology Department, Brest University Hospital., Moreau A; Pathology Department, Nantes University Hospital., Carras S; Onco-Hematology Department, Grenoble University Hospital., Tchernonog E; Hematology Department, Montpellier University Hospital., Schmitt A; Hematology Department, Cancer Institute Bergonie Bordeaux., Houot R; Hematology Department, Rennes University Hospital., Dartigeas C; Hematology Department, Tours University Hospital., Pignon JM; Hematology Department, Dunkerque Hospital., Corm S; Hematology Department, Chambery Hospital., Banos A; Hematology Department, Bayonne Hospital., Mounier C; Hematology Department, Loire Cancer Institute, Saint Etienne., Dupuis J; Lymphoid Malignancies Unit, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil., Macro M; IHBN - Hematology Department, Caen University Hospital., Fleury J; Hematology Department, Clermont-Ferrand Cancer Institute., Jardin F; Hematology Department, Rouen University Hospital., Sarkozy C; Hematology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud. INSERM 1052., Damaj G; Hematology Department, Amiens University Hospital., Feugier P; Hematology Department, Nancy University Hospital., Fornecker LM; Hematology Department, University Hospital Strasbourg., Chabrot C; Hematology Department, University Clermont-Ferrand Hospital., Dorvaux V; Hematology Department, Metz University Hospital., Bouadallah K; Hematology Department, Bordeaux University Hospital., Amorin S; Hematology Department, University Hospital Paris Saint-Louis., Garidi R; Hematology Department, Saint Quentin Hospital., Voillat L; Hematology Department, Chalon Hospital., Joly B; Hematology Department, Corbeil Hospital., Celigny PS; Hematology Department, Victor Hugo Clinic, Le Mans., Morineau N; Hematology Department, Catherine de Sienne Clinic, Nantes., Moles MP; Hematology Department, Angers University Hospital., Zerazhi H; Hematology Department, Avignon Hospital., Fontan J; Hematology Department, Besançon University Hospital., Arkam Y; Hematology Department, Mulhouse Hospital., Alexis M; Hematology Department, Orleans Hospital., Delwail V; Onco-Hematology Department, University Hospital Poitiers and INSERM, CIC 1402, Poitiers University., Vilque JP; Hematology Department, Baclesse Caen Cancer Center., Ysebaert L; Hematology Department, Toulouse University Hospital., Le Gouill S; Hematology Department, Nantes University Hospital., Callanan MB; INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble-Alpes, Institute for Advanced Biosciences, Grenoble rgressin@chu-grenoble.fr mary.callanan@chu-dijon.fr.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, France.
Corporate Authors: Lymphoma Study Association
Source: Haematologica [Haematologica] 2019 Jan; Vol. 104 (1), pp. 138-146. Date of Electronic Publication: 2018 Aug 31.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30171024
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gressin+R%22">Gressin R</searchLink>; Onco-Hematology Department, Grenoble University Hospital rgressin@chu-grenoble.fr mary.callanan@chu-dijon.fr.; INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble-Alpes, Institute for Advanced Biosciences, Grenoble.<br /><searchLink fieldCode="AU" term="%22Daguindau+N%22">Daguindau N</searchLink>; Hematology Department, Annecy Hospital.<br /><searchLink fieldCode="AU" term="%22Tempescul+A%22">Tempescul A</searchLink>; Hematology Department, Brest University Hospital.<br /><searchLink fieldCode="AU" term="%22Moreau+A%22">Moreau A</searchLink>; Pathology Department, Nantes University Hospital.<br /><searchLink fieldCode="AU" term="%22Carras+S%22">Carras S</searchLink>; Onco-Hematology Department, Grenoble University Hospital.<br /><searchLink fieldCode="AU" term="%22Tchernonog+E%22">Tchernonog E</searchLink>; Hematology Department, Montpellier University Hospital.<br /><searchLink fieldCode="AU" term="%22Schmitt+A%22">Schmitt A</searchLink>; Hematology Department, Cancer Institute Bergonie Bordeaux.<br /><searchLink fieldCode="AU" term="%22Houot+R%22">Houot R</searchLink>; Hematology Department, Rennes University Hospital.<br /><searchLink fieldCode="AU" term="%22Dartigeas+C%22">Dartigeas C</searchLink>; Hematology Department, Tours University Hospital.<br /><searchLink fieldCode="AU" term="%22Pignon+JM%22">Pignon JM</searchLink>; Hematology Department, Dunkerque Hospital.<br /><searchLink fieldCode="AU" term="%22Corm+S%22">Corm S</searchLink>; Hematology Department, Chambery Hospital.<br /><searchLink fieldCode="AU" term="%22Banos+A%22">Banos A</searchLink>; Hematology Department, Bayonne Hospital.<br /><searchLink fieldCode="AU" term="%22Mounier+C%22">Mounier C</searchLink>; Hematology Department, Loire Cancer Institute, Saint Etienne.<br /><searchLink fieldCode="AU" term="%22Dupuis+J%22">Dupuis J</searchLink>; Lymphoid Malignancies Unit, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil.<br /><searchLink fieldCode="AU" term="%22Macro+M%22">Macro M</searchLink>; IHBN - Hematology Department, Caen University Hospital.<br /><searchLink fieldCode="AU" term="%22Fleury+J%22">Fleury J</searchLink>; Hematology Department, Clermont-Ferrand Cancer Institute.<br /><searchLink fieldCode="AU" term="%22Jardin+F%22">Jardin F</searchLink>; Hematology Department, Rouen University Hospital.<br /><searchLink fieldCode="AU" term="%22Sarkozy+C%22">Sarkozy C</searchLink>; Hematology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud. INSERM 1052.<br /><searchLink fieldCode="AU" term="%22Damaj+G%22">Damaj G</searchLink>; Hematology Department, Amiens University Hospital.<br /><searchLink fieldCode="AU" term="%22Feugier+P%22">Feugier P</searchLink>; Hematology Department, Nancy University Hospital.<br /><searchLink fieldCode="AU" term="%22Fornecker+LM%22">Fornecker LM</searchLink>; Hematology Department, University Hospital Strasbourg.<br /><searchLink fieldCode="AU" term="%22Chabrot+C%22">Chabrot C</searchLink>; Hematology Department, University Clermont-Ferrand Hospital.<br /><searchLink fieldCode="AU" term="%22Dorvaux+V%22">Dorvaux V</searchLink>; Hematology Department, Metz University Hospital.<br /><searchLink fieldCode="AU" term="%22Bouadallah+K%22">Bouadallah K</searchLink>; Hematology Department, Bordeaux University Hospital.<br /><searchLink fieldCode="AU" term="%22Amorin+S%22">Amorin S</searchLink>; Hematology Department, University Hospital Paris Saint-Louis.<br /><searchLink fieldCode="AU" term="%22Garidi+R%22">Garidi R</searchLink>; Hematology Department, Saint Quentin Hospital.<br /><searchLink fieldCode="AU" term="%22Voillat+L%22">Voillat L</searchLink>; Hematology Department, Chalon Hospital.<br /><searchLink fieldCode="AU" term="%22Joly+B%22">Joly B</searchLink>; Hematology Department, Corbeil Hospital.<br /><searchLink fieldCode="AU" term="%22Celigny+PS%22">Celigny PS</searchLink>; Hematology Department, Victor Hugo Clinic, Le Mans.<br /><searchLink fieldCode="AU" term="%22Morineau+N%22">Morineau N</searchLink>; Hematology Department, Catherine de Sienne Clinic, Nantes.<br /><searchLink fieldCode="AU" term="%22Moles+MP%22">Moles MP</searchLink>; Hematology Department, Angers University Hospital.<br /><searchLink fieldCode="AU" term="%22Zerazhi+H%22">Zerazhi H</searchLink>; Hematology Department, Avignon Hospital.<br /><searchLink fieldCode="AU" term="%22Fontan+J%22">Fontan J</searchLink>; Hematology Department, Besançon University Hospital.<br /><searchLink fieldCode="AU" term="%22Arkam+Y%22">Arkam Y</searchLink>; Hematology Department, Mulhouse Hospital.<br /><searchLink fieldCode="AU" term="%22Alexis+M%22">Alexis M</searchLink>; Hematology Department, Orleans Hospital.<br /><searchLink fieldCode="AU" term="%22Delwail+V%22">Delwail V</searchLink>; Onco-Hematology Department, University Hospital Poitiers and INSERM, CIC 1402, Poitiers University.<br /><searchLink fieldCode="AU" term="%22Vilque+JP%22">Vilque JP</searchLink>; Hematology Department, Baclesse Caen Cancer Center.<br /><searchLink fieldCode="AU" term="%22Ysebaert+L%22">Ysebaert L</searchLink>; Hematology Department, Toulouse University Hospital.<br /><searchLink fieldCode="AU" term="%22Le+Gouill+S%22">Le Gouill S</searchLink>; Hematology Department, Nantes University Hospital.<br /><searchLink fieldCode="AU" term="%22Callanan+MB%22">Callanan MB</searchLink>; INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble-Alpes, Institute for Advanced Biosciences, Grenoble rgressin@chu-grenoble.fr mary.callanan@chu-dijon.fr.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Lymphoma+Study+Association%22">Lymphoma Study Association</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2019 Jan; Vol. 104 (1), pp. 138-146. <i>Date of Electronic Publication: </i>2018 Aug 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30171024
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2018.191429
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 138
    Titles:
      – TitleFull: A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gressin R
      – PersonEntity:
          Name:
            NameFull: Daguindau N
      – PersonEntity:
          Name:
            NameFull: Tempescul A
      – PersonEntity:
          Name:
            NameFull: Moreau A
      – PersonEntity:
          Name:
            NameFull: Carras S
      – PersonEntity:
          Name:
            NameFull: Tchernonog E
      – PersonEntity:
          Name:
            NameFull: Schmitt A
      – PersonEntity:
          Name:
            NameFull: Houot R
      – PersonEntity:
          Name:
            NameFull: Dartigeas C
      – PersonEntity:
          Name:
            NameFull: Pignon JM
      – PersonEntity:
          Name:
            NameFull: Corm S
      – PersonEntity:
          Name:
            NameFull: Banos A
      – PersonEntity:
          Name:
            NameFull: Mounier C
      – PersonEntity:
          Name:
            NameFull: Dupuis J
      – PersonEntity:
          Name:
            NameFull: Macro M
      – PersonEntity:
          Name:
            NameFull: Fleury J
      – PersonEntity:
          Name:
            NameFull: Jardin F
      – PersonEntity:
          Name:
            NameFull: Sarkozy C
      – PersonEntity:
          Name:
            NameFull: Damaj G
      – PersonEntity:
          Name:
            NameFull: Feugier P
      – PersonEntity:
          Name:
            NameFull: Fornecker LM
      – PersonEntity:
          Name:
            NameFull: Chabrot C
      – PersonEntity:
          Name:
            NameFull: Dorvaux V
      – PersonEntity:
          Name:
            NameFull: Bouadallah K
      – PersonEntity:
          Name:
            NameFull: Amorin S
      – PersonEntity:
          Name:
            NameFull: Garidi R
      – PersonEntity:
          Name:
            NameFull: Voillat L
      – PersonEntity:
          Name:
            NameFull: Joly B
      – PersonEntity:
          Name:
            NameFull: Celigny PS
      – PersonEntity:
          Name:
            NameFull: Morineau N
      – PersonEntity:
          Name:
            NameFull: Moles MP
      – PersonEntity:
          Name:
            NameFull: Zerazhi H
      – PersonEntity:
          Name:
            NameFull: Fontan J
      – PersonEntity:
          Name:
            NameFull: Arkam Y
      – PersonEntity:
          Name:
            NameFull: Alexis M
      – PersonEntity:
          Name:
            NameFull: Delwail V
      – PersonEntity:
          Name:
            NameFull: Vilque JP
      – PersonEntity:
          Name:
            NameFull: Ysebaert L
      – PersonEntity:
          Name:
            NameFull: Le Gouill S
      – PersonEntity:
          Name:
            NameFull: Callanan MB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2019 Jan
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 104
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1